terbutaline has been researched along with Respiratory Distress Syndrome, Newborn in 10 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective, randomized study was conducted comparing the use of betamethasone and early delivery, early delivery alone, and expectant management in patients in the 28th to 34th week of pregnancy with premature rupture of the membranes (PROM)." | 5.05 | Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. ( Dillard, R; Ernest, JM; Hatjis, CG; Meis, PJ; Nelson, LH; Schey, HM, 1985) |
| "The use of tocolytic agents to halt premature labor is controversial." | 1.30 | Association of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung Project. ( Evans, M; Lim, TS; McGuinness, G; Palta, M; Sadek, M, 1998) |
| "Terbutaline is a beta-sympathomimetic agent that has gained wide use in obstetrics as a tocolytic agent." | 1.28 | Long-term subcutaneous terbutaline tocolysis: report of possible neonatal toxicity. ( Loughead, JL; Thorkelsson, T, 1991) |
| "Issues of the pharmacologic therapy of preterm labor, enhancement of lung maturity, and management of labor and delivery are discussed." | 1.27 | Obstetric management of the very low birth weight fetus. ( Hayashi, RH; Marshall, CL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fayon, M | 1 |
| Tayara, N | 1 |
| Germain, C | 1 |
| Choukroun, ML | 1 |
| De La Roque, ED | 1 |
| Chêne, G | 1 |
| Breilh, D | 1 |
| Marthan, R | 1 |
| Demarquez, JL | 1 |
| Takahashi, Y | 1 |
| Ukita, M | 1 |
| Nakada, E | 1 |
| Tachibana, Y | 1 |
| Nishizawa, K | 1 |
| Takakura, K | 1 |
| Emi, N | 1 |
| Palta, M | 1 |
| Sadek, M | 1 |
| Lim, TS | 1 |
| Evans, M | 1 |
| McGuinness, G | 1 |
| Robinson, BV | 1 |
| Ettedgui, JA | 1 |
| Sherman, FS | 1 |
| Thorkelsson, T | 1 |
| Loughead, JL | 1 |
| Kalstone, C | 1 |
| Taslimi, MM | 1 |
| Sibai, BM | 1 |
| Amon, E | 1 |
| Taslimi, CK | 1 |
| Herrick, CN | 1 |
| Marshall, CL | 1 |
| Hayashi, RH | 1 |
| Phuapradit, W | 1 |
| Pongthai, S | 1 |
| Chaturachinda, K | 1 |
| Nelson, LH | 1 |
| Meis, PJ | 1 |
| Hatjis, CG | 1 |
| Ernest, JM | 1 |
| Dillard, R | 1 |
| Schey, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)[NCT00005289] | 2,202 participants (Actual) | Observational | 1987-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for terbutaline and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates.
Topics: Administration, Inhalation; Airway Resistance; Birth Weight; Bronchodilator Agents; Cross-Over Studi | 2007 |
Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management.
Topics: Bacterial Infections; Betamethasone; Delivery, Obstetric; Female; Fetal Membranes, Premature Rupture | 1985 |
8 other studies available for terbutaline and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
[Neonatal survival and perinatal factors in infants born at 24 to 32 weeks of gestation].
Topics: Apgar Score; Betamethasone; Birth Weight; Cerebral Hemorrhage; Delivery, Obstetric; Female; Gestatio | 1984 |
Association of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung Project.
Topics: Cerebral Hemorrhage; Cohort Studies; Confidence Intervals; Databases, Factual; Drug Therapy, Combina | 1998 |
Use of terbutaline in the treatment of complete heart block in the fetus.
Topics: Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Echocardiography; Female; Fetal Diseases | 2001 |
Long-term subcutaneous terbutaline tocolysis: report of possible neonatal toxicity.
Topics: Acidosis, Respiratory; Adult; Female; Heart; Heart Rate; Humans; Infant, Newborn; Infant, Premature; | 1991 |
Successful antepartum treatment of listeriosis.
Topics: Adult; Ampicillin; Cesarean Section; Female; Humans; Infant, Newborn; Injections, Intravenous; Liste | 1991 |
A national survey on preterm labor.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Amniocentesis; Attitude of Health Personne | 1989 |
Obstetric management of the very low birth weight fetus.
Topics: Adrenal Cortex Hormones; Extraction, Obstetrical; Female; Fetal Distress; Fetal Monitoring; Fetal Or | 1986 |
A five-year experience with terbutaline for preterm labor.
Topics: Combined Modality Therapy; Dexamethasone; Female; Gestational Age; Humans; Infant, Newborn; Obstetri | 1986 |